• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Apoptosis-related protein 3 (41367), Truncated

ACP16449

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP16449 Target NameATRAID
Target SynonymsATRAID; APR3; C2orf28; HSPC013; UNQ214/PRO240; All-trans retinoic acid-induced differentiation factor; Apoptosis-related protein 3; APR-3; p18FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ6UW56
Background Information
  • Uniprot Id

    Q6UW56

  • Target Species

    Human

  • Target Name

    ATRAID

  • Target Full Name

    All-trans retinoic acid-induced differentiation factor

  • Target Function

    Promotes osteoblast cell differentiation and terminal mineralization. Plays a role in inducing the cell cycle arrest via inhibiting CCND1 expression in all-trans-retinoic acid (ATRA) signal pathway.

  • Target Subcellular Location

    Nucleus envelope. Cell membrane; Single-pass membrane protein. Note=Colocalizes with NELL1 on the nuclear envelope and the perinuclear region (PubMed:21723284).

  • Target Tissue Specificity

    Weakly expressed in hematopoietic cell lines.

  • Target Synonyms

    ATRAID; APR3; C2orf28; HSPC013; UNQ214/PRO240; All-trans retinoic acid-induced differentiation factor; Apoptosis-related protein 3; APR-3; p18

Inquire Recombinant Human Apoptosis-related protein 3 (41367), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification